Skip to main content

Weonsang Simon Ro

Kyung Hee University

研究室紹介

Professor Weonsang Simon Ro's research lab specializes in translational cancer biology, with a focus on molecular mechanisms underlying hepatocellular carcinoma (HCC) and the repurposing of immunosuppressive drugs for cancer therapy. The lab investigates the therapeutic potential of low-dose rapamycin and other mTOR inhibitors in preventing and treating HCC in preclinical models, particularly in genetically engineered mouse models that mimic human HCC pathogenesis. Current research also explores combination therapies involving immunosuppressants to balance anti-tumor efficacy with immune regulation. The lab aims to bridge basic cancer biology with clinical applications, particularly in liver cancer prevention and treatment strategies.

hepatocellular carcinomarapamycinmTOR inhibitiontranslational cancer researchimmunosuppressant repurposing

Research Overview

Papers
1
Total Citations
3
Papers (5y)
1
Primary Field

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
1total
2022
Citations per year (5y)
3total
2022

Selected Papers

1
1
Article|3 citations·2022
Antitumor Effect of Low-Dose of Rapamycin in a Transgenic Mouse Model of Liver Cancer
이형순, 김준예, 노원상, 김명수, 김혜령, 주동진
https://www.eymj.org/DOIx.php?id=10.3349/ymj.2022.0247

Purpose: We investigate whether low-dose rapamycin is effective in preventing hepatocellular carcinoma (HCC) growth and treating HCC after tumor development in transgenic mice. Materials and Methods: We established transgenic mice with HCC induced by activated HrasG12V and p53 suppression. Trans genic mice were randomly assigned to five experimental groups: negative control, positive control, tacrolimus only, rapamycin only, and tacrolimus plus rapamycin. The mice were further divided into two g

Weonsang Simon Roの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。